Company: Department of Clinical Affairs | Dendreon Corporation
Location: Seattle, WA
Seattle, Washington, January 26, 2011, Jayne Meyer, Senior Clinical Trial Associate for Dendreon Corporation, has been recognized by Elite American Nurses for dedication, achievements, and leadership in clinical trial management.
An impassioned nurse, Ms. Meyer has demonstrated poise and professionalism for 36 years in the field of clinical trials. Her responsibilities are numerous and diverse, and include acting as a liaison for multiple clinical organizations, leading a clinical affairs standard operating procedure program, and coordinating registration for clinical trial subjects and training for the clinical affairs department. In addition to managing projects for immunotherapy protocol, Ms. Meyer serves as an administrative clinical research associate for the trial sites.
Previously, Ms. Meyer worked as a manager of clinical affairs for Xcyte Therapies, Inc., a clinical research associate for SangStat Medical Corporation in Fremont, California, a clinical transplant coordinator for the University of Washington Medical Center and the Methodist Medical Center in Dallas, Texas, and an ICU staff nurse. Ms Meyer’s compassion toward her patients and contributions as a team member has led to accomplishments for both her organization and her professional reputation.
Ms. Meyer earned a Bachelor of Arts in nursing from Augustana College in Sioux Falls, South Dakota. In addition, she holds prior certifications in clinical transplant coordination, CPR and advanced cardiac life support. To keep abreast of her industry, Ms. Meyer is professionally affiliated with the Society of Clinical Research Associates, and retains contacts from her former association with the North American Transplant Coordinators Organization and the International Society for Heart & Lung Transplantation.
Based on her extensive research, Ms. Meyer has published conclusions in numerous industry-related publications. Notably, “Correlation of History to Clinical Rejection Reversal: A Thymoglobulin Multicenter Trial Report” was published in the 55th volume of Kidney International in 1999. Looking forward, Ms. Meyer intends to continue working in biotechnology to attain a more advanced role in the industry.
Contact Jayne Meyer